audeo oncology website, page-21

IMO its the same across the board with most companies not just ACL. In these times people want to see the runs on the score card. Not speculation. That is sales figures, payments, and projections based on facts. Dr R Sales are going great but we can't tell you anything isn't going to be rewarded at the moment. When they say debt is cleared, cash is rolling in etc etc I would expect a rerating.